8-K
Current Report
Spyre Therapeutics, Inc. Filed Acc 0001636282-24-000105
Restatement · Other events
- Item 4.02 Non-reliance on previously issued financial statements
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading syre-20241118.htm…